We only have this paper's title and publication details.
Read it at the sourceThe RNA-based GemPred stratification predicts the benefit of adjuvant gemcitabine in PDAC patients.
No takes yet. Share an insight, caveat, or question.
Nicolle et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: